Current and future use of umifenovir in patients with COVID-19

• Main Authors: Yu. Yu. Kiselev (Author), K. A. Zagorodnikova (Author), D. V. Ivashchenko (Author), A. V. Krykov (Author), I. N. Sychev (Author), A. S. Matveev (Author), K. B. Mirzaev (Author), V. A. Otdelenov (Author), V. M. Tsvetov (Author), A. V. Dmitriev (Author), V. V. Poroikov (Author), D. A. Sychev (Author)
• Format: Book
• Published: Izdatelstvo OKI, 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

At the time of print, the evidence for using umifenovir in COVID-19 is mainly theoretical. The published clinical trials have contradicting results. The decision to use umifenovir in COVID-19 should be individualized, considering the "experimental" nature of this treatment.